News | January 26, 2021
Aurobindo Pharma gets approval for 3 products under PLI Scheme: ICICI Securities
Post approval under the PLI scheme, Aurobindo will become a very large player in anti-biotic space.
Post approval under the PLI scheme, Aurobindo will become a very large player in anti-biotic space.
The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies
The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore
The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit
Initiative aims to strengthen South-South collaboration and capacity building in biomedical research
Hair care & quick commerce shine
With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
Subscribe To Our Newsletter & Stay Updated
